Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Journal of Child Neurology
|
November 26, 2004
Non-neurologic manifestations of tuberous sclerosis complex
David Neal Franz
Expert Review of Anticancer Therapy
|
September 16, 2011
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
David Neal Franz
Biologics : Targets & Therapy
|
October 22, 2013
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
David Neal Franz
Expert Review of Neurotherapeutics
|
July 24, 2019
Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures
Lorena Lechuga, David Neal Franz
Expert Opinion on Pharmacotherapy
|
April 28, 2020
Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA)
Daniel Ebrahimi-Fakhari, David Neal Franz
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
October 12, 2018
mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex
David Neal Franz, Darcy Andrew Krueger
Neuropsychiatric Disease and Treatment
|
September 8, 2016
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
Jamie K Capal, David Neal Franz
Current Neurology and Neuroscience Reports
|
May 1, 2012
Molecular therapies for tuberous sclerosis and neurofibromatosis
David Neal Franz, Brian D Weiss
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses
|
July 2, 2013
Nursing implications for the lifelong management of tuberous sclerosis complex
Karen Agricola, Cindy Tudor, Darcy Krueger, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 10, 2026
Approved Targeted Treatments for Pediatric Brain Tumors
Eric Bouffet, David Neal Franz, Isabel Arrillaga-Romany, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Journal of Child Neurology
|
November 26, 2004
Non-neurologic manifestations of tuberous sclerosis complex
David Neal Franz
Expert Review of Anticancer Therapy
|
September 16, 2011
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
David Neal Franz
Biologics : Targets & Therapy
|
October 22, 2013
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
David Neal Franz
Expert Review of Neurotherapeutics
|
July 24, 2019
Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures
Lorena Lechuga, David Neal Franz
Expert Opinion on Pharmacotherapy
|
April 28, 2020
Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA)
Daniel Ebrahimi-Fakhari, David Neal Franz
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
October 12, 2018
mTOR inhibitor therapy as a disease modifying therapy for tuberous sclerosis complex
David Neal Franz, Darcy Andrew Krueger
Neuropsychiatric Disease and Treatment
|
September 8, 2016
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
Jamie K Capal, David Neal Franz
Current Neurology and Neuroscience Reports
|
May 1, 2012
Molecular therapies for tuberous sclerosis and neurofibromatosis
David Neal Franz, Brian D Weiss
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses
|
July 2, 2013
Nursing implications for the lifelong management of tuberous sclerosis complex
Karen Agricola, Cindy Tudor, Darcy Krueger, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 10, 2026
Approved Targeted Treatments for Pediatric Brain Tumors
Eric Bouffet, David Neal Franz, Isabel Arrillaga-Romany, et al.
Page
of 4